KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Treasury Shares (2017 - 2026)

TherapeuticsMD filings provide 11 years of Treasury Shares readings, the most recent being $26000.0 for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 420.0% to $26000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $26000.0, a 420.0% increase, with the full-year FY2025 number at $26000.0, changed 0.0% from a year prior.
  • Treasury Shares hit $26000.0 in Q1 2026 for TherapeuticsMD, roughly flat from $26000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $177000.0 in Q1 2023 to a low of $38.0 in Q1 2024.
  • Median Treasury Shares over the past 5 years was $26000.0 (2024), compared with a mean of $46602.5.
  • Biggest five-year swings in Treasury Shares: crashed 99.98% in 2024 and later surged 13057.89% in 2025.
  • TherapeuticsMD's Treasury Shares stood at $19000.0 in 2022, then surged by 110.53% to $40000.0 in 2023, then plummeted by 35.0% to $26000.0 in 2024, then changed by 0.0% to $26000.0 in 2025, then changed by 0.0% to $26000.0 in 2026.
  • The last three reported values for Treasury Shares were $26000.0 (Q1 2026), $26000.0 (Q4 2025), and $5000.0 (Q1 2025) per Business Quant data.